|
ABCA7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.799000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.037400E-03 |
| Normal-vs-Stage2 |
2.508000E-02 |
| Normal-vs-Stage3 |
1.854370E-01 |
| Normal-vs-Stage4 |
5.097800E-02 |
| Stage1-vs-Stage2 |
7.526200E-01 |
| Stage1-vs-Stage3 |
1.716350E-01 |
| Stage1-vs-Stage4 |
7.443000E-01 |
| Stage2-vs-Stage3 |
2.086000E-01 |
| Stage2-vs-Stage4 |
5.865800E-01 |
| Stage3-vs-Stage4 |
4.770800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.094310E-02 |
| Normal-vs-AfricanAmerican |
1.402570E-01 |
| Normal-vs-Asian |
1.440210E-02 |
| Caucasian-vs-AfricanAmerican |
7.116600E-01 |
| Caucasian-vs-Asian |
5.442000E-01 |
| AfricanAmerican-vs-Asian |
4.587800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.477860E-03 |
| Normal-vs-Female |
2.148200E-02 |
| Male-vs-Female |
7.506500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.679700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.870100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.664000E-02 |
| Normal-vs-Age(81-100Yrs) |
6.333600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.898390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.922000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.276800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.518600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.799200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.880000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.053600E-02 |
| Classical-VS-Follicular |
4.018000E-01 |
| Classical-VS-Other |
6.112600E-01 |
| Classical-VS-Normal |
5.763500E-03 |
| Tall-VS-Follicular |
8.840800E-03 |
| Tall-VS-Other |
2.561400E-01 |
| Tall-VS-Normal |
6.206400E-01 |
| Follicular-VS-Other |
7.303800E-01 |
| Follicular-VS-Normal |
3.724800E-03 |
| Other-VS-Normal |
3.097800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.837100E-04 |
| Normal-vs-N1 |
8.817400E-03 |
| N0-vs-N1 |
8.961200E-01 |
|
|
